Insiders who reported open-market trades in the last 12 months at the companies Traci S. Umberger files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Traci S. Umberger is a corporate insider, tracked as General Counsel and Chief Adminstrative Officer, Director of KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Traci S. Umberger submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Traci S. Umberger been buying or selling stock?
Recorded transactions: 1 open-market purchase ($230K) and 5 open-market sales ($879K) across all tracked filings.
Traci S. Umberger is General Counsel and Chief Adminstrative Officer, Director of KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS). 8 SEC Form 4 filings on record going back to 2025, most recently on 6 August 2026. Most recent open-market trade: sold $86K of KMTS on 6 August 2026. Lifetime open-market purchases: $230K. Lifetime open-market sales: $879K.
Recent transactions
10
The latest 10 SEC Form 4 transactions reported by Traci S. Umberger.
InsiderAlpha's records for Traci S. Umberger go back to 2025: 8 primary Form 4 filings, an average of 4.0 per year. The typical open-market purchase is $230K (1 buy totaling $230K). The largest single buy on record is $230K of KMTS in 2025. Sales side: 5 recorded sales totaling $879K, so the filing history runs sell-heavy by dollar value. 1 recorded transaction carries a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
